Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

575
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
575
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

688
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
688
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

977
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
977

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cellular Immunological Memory T Cells and <i>IL15RA</i> Gene Polymorphism in COVID-19 Vaccinated Individuals from Southern Brazil.

Diagnostics (Basel, Switzerland)·2026
Same author

Ganciclovir Resistance-Linked Mutations in the HCMV <i>UL97</i> Gene: Sanger Sequencing Analysis in Samples from Transplant Recipients at a Tertiary Hospital in Southern Brazil.

Diagnostics (Basel, Switzerland)·2025
Same author

Integrated molecular profiling of <i>RAS</i>, <i>BRAF</i> mutations, and mismatch repair status in advanced colorectal carcinoma: insights from gender and tumor laterality.

Journal of gastrointestinal oncology·2024
Same author

SARS-CoV-2 Variants of Concern: Presumptive Identification via Sanger Sequencing Analysis of the Receptor Binding Domain (RBD) Region of the <i>S</i> Gene.

Diagnostics (Basel, Switzerland)·2023
Same author

RT-qPCR half-reaction optimization for the detection of SARS-CoV-2.

Revista da Sociedade Brasileira de Medicina Tropical·2021
Same author

SARS-CoV-2 nucleic acid shedding is variable for every person.

Revista da Sociedade Brasileira de Medicina Tropical·2021

相关实验视频

Updated: Feb 28, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K

结核病诊断方法:临床适用性,实施挑战和综合测试策略

Eduarda Rabello1, Fernanda de-Paris2

  • 1Specialization in Clinical Microbiology, Institute of Basic Health Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, RS, Brazil.

Pathogens (Basel, Switzerland)
|February 27, 2026
PubMed
概括

结核病诊断面临各种实验室方法,艾滋病毒和耐药性等挑战. 本综述考察了从实施和现实世界的约束来改善全球结核病战略的诊断工具.

关键词:
诊断 诊断 诊断 诊断 诊断 诊断诊断测试 诊断测试 测试 诊断测试灵敏度 灵敏度 灵敏度 灵敏度 灵敏度特殊性的特异性结核病是一种肺结核病.

更多相关视频

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

82.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

相关实验视频

Last Updated: Feb 28, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
08:10

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

82.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.2K

科学领域:

  • 微生物学 微生物学
  • 传染性疾病 传染性疾病
  • 公共卫生 公共卫生

背景情况:

  • 结核病 (TB) 是全球主要的传染病死亡原因,由艾滋病毒和耐药性恶化.
  • 现有的结核病诊断方法在不同医疗机构的适用性和影响方面各不相同.
  • 需要对结核病诊断进行实用,以实施为重点的审查.

研究的目的:

  • 为活跃和潜伏结核病提供实验室诊断方法的全面概述.
  • 强调临床适用性,实施挑战和在诊断策略中的整合.
  • 采用以实施为导向的视角,考虑到现实世界的限制和区域差异.

主要方法:

  • 对传统方法 (涂层显微镜,培养) 和现代技术 (NAAT,LAMP,LPA,NGS,横流测定) 的审查.
  • 基于现实世界的限制,区域差异和证据差距的诊断方法的批判性检查.
  • 整合世卫组织指导与上下文和操作方面的考虑.

主要成果:

  • 各种结核病诊断方法的优点和局限性在不同的背景下得到了强调.
  • 讨论了包括基础设施,生物安全,劳动力和可持续性在内的实施挑战.
  • 考虑了诸如潜伏结核病和共致病原体调查等未得到解决的领域.

结论:

  • 合理的测试选择和综合诊断工作流程对于加强结核病战略至关重要.
  • 根据当地卫生系统能力和患者人群量身定制诊断方法对于有效性和公平性至关重要.
  • 这一审查支持全球结核病诊断实施的知情决策.